Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma

Tumor Biology

Volumn 37, Issue 4, 2016, Pages 4523-4529

  An, Huimin ^a,b   Zhu, Yu ^a,b   Xie, Huyang ^a,b   Liu, Yidong ^b   Liu, Weisi ^b   Fu, Qiang ^b   Ye, Dingwei ^a,b   Xu, Jiejie ^b,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cancer specific survival; Clear cell renal cell carcinoma; Interleukin 8; Prognostic biomarker; Relapse free survival

Indexed keywords

INTERLEUKIN 8; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; FEMALE; FUHRMAN GRADE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; AGED; AREA UNDER THE CURVE; CARCINOMA, RENAL CELL; KAPLAN MEIER METHOD; KIDNEY NEOPLASMS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; TREATMENT OUTCOME;

EID: 84945313304     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4158-8     Document Type: Article

References (28)

1. Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60:615–21.
2. Sun M, Lughezzani G, Perrotte P, Karakiewicz PI. Treatment of metastatic renal cell carcinoma. Nat Rev Urol. 2010;7:327–38.
3. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001;12:375–91.
4. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A. 2001;98:9754–9.
5. Malouf GG, Monzon FA, Couturier J, Molinie V, Escudier B, Camparo P, et al. Genomic heterogeneity of translocation renal cell carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2013;19:4673–84.
6. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6:447–58.
7. Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, et al. Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Cancer Res. 2010;70:1063–71.
8. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–7.
9. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307:97–101.
10. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science. 1991;253:1278–80.
11. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:6735–41.
12. Abraham RT. Chemokine to the rescue: interleukin-8 mediates resistance to pi3k-pathway-targeted therapy in breast cancer. Cancer Cell. 2012;22:703–5.
13. Chavey C, Muhlbauer M, Bossard C, Freund A, Durand S, Jorgensen C, et al. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappab pathway in breast cancer. Mol Pharmacol. 2008;74:1359–66.
14. Zhang Y, Wang L, Zhang M, Jin M, Bai C, Wang X. Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of egf-egfr-pi3k-akt-erk pathway. J Cell Physiol. 2012;227:35–43.
15. Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston PG, et al. Nonapical and cytoplasmic expression of interleukin-8, cxcr1, and cxcr2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:4117–27.
16. Konig B, Steinbach F, Janocha B, Drynda A, Stumm M, Philipp C, et al. The differential expression of proinflammatory cytokines il-6, il-8 and tnf-alpha in renal cell carcinoma. Anticancer Res. 1999;19:1519–24.
17. Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. The role of cxcr2/cxcr2 ligand biological axis in renal cell carcinoma. J Immunol. 2005;175:5351–7.
18. Grepin R, Guyot M, Giuliano S, Boncompagni M, Ambrosetti D, Chamorey E, et al. The cxcl7/cxcr1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Cancer Res. 2014;74:873–83.
19. Inozume T, Hanada K, Wang QJ, Yang JC. Il-17 secreted by tumor reactive t cells induces il-8 release by human renal cancer cells. J Immunother. 2009;32:109–17.
20. Takamori H, Oades ZG, Hoch OC, Burger M, Schraufstatter IU. Autocrine growth effect of il-8 and groalpha on a human pancreatic cancer cell line, capan-1. Pancreas. 2000;21:52–6.
21. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 2000;12:78–85.
22. Lang K, Niggemann B, Zanker KS, Entschladen F. Signal processing in migrating t24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop. Int J Cancer. 2002;99:673–80.
23. Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W, et al. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer. 2007;121:1949–57.
24. Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J, et al. Hif-1 and nf-kappab-mediated upregulation of cxcr1 and cxcr2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene. 2007;26:7333–45.
25. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, et al. Fully humanized neutralizing antibodies to interleukin-8 (abx-il8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002;161:125–34.
26. Shi Q, Abbruzzese JL, Huang S, Fidler IJ, Xiong Q, Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res Off J Am Assoc Cancer Res. 1999;5:3711–21.
27. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappab. Clin Cancer Res Off J Am Assoc Cancer Res. 2003;9:3167–75.
28. Slaton JW, Inoue K, Perrotte P, El-Naggar AK, Swanson DA, Fidler IJ, et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol. 2001;158:735–43.